STOCK TITAN

Core Scientific: MFN Partners reports 7.6% stake

A reported 7.6% position includes 16,700,000 common shares and 7,788,600 shares issuable upon option exercise.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Core Scientific, Inc. (CORZ) is the issuer in a Schedule 13G reporting shared voting and dispositive power over 24,488,600 shares, listed as 7.6% of the class. The reporting persons are MFN Partners, LP; MFN Partners GP, LLC; MFN Partners Management, LP; MFN Partners Management, LLC; Michael F. DeMichele; and Farhad Nanji. The reported amount comprises 16,700,000 shares of common stock and 7,788,600 shares issuable upon exercise of options. The filing identifies MFN Partners, LP as the direct holder; each reporting person disclaims beneficial ownership except to the extent of its or his pecuniary interest. The percentage calculation uses 321,340,441 common shares outstanding as of July 23, 2026. DeMichele and Nanji are managing members of MFN GP and MFN LLC.

Reported beneficial ownership 24,488,600 shares Shared voting and dispositive power reported
Percent of class 7.6% Based on shares outstanding as of July 23, 2026
Common stock 16,700,000 shares Included in the reported amount
Shares issuable upon exercise of options 7,788,600 shares Included in the reported amount
Common shares outstanding 321,340,441 shares As of July 23, 2026
beneficial ownership regulatory
"Amount beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Power regulatory
"Shared Voting Power 24,488,600.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 24,488,600.00"
pecuniary interest regulatory
"except to the extent of its or his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CORZ shares do the reporting persons report?

The reporting persons report shared voting and dispositive power over 24,488,600 shares, listed as 7.6% of the class. The reported amount comprises 16,700,000 shares of common stock and 7,788,600 shares issuable upon exercise of options.

Who directly holds the reported CORZ shares?

The filing identifies MFN Partners, LP as the direct holder. The reporting persons also include MFN Partners GP, LLC; MFN Partners Management, LP; MFN Partners Management, LLC; Michael F. DeMichele; and Farhad Nanji.

What share count was used to calculate the CORZ ownership percentage?

The 7.6% calculation is based on 321,340,441 shares of common stock outstanding as of July 23, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates





21874A106

(CUSIP Number)
10/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The shares represented in Rows 6, 8 and 9 consist of i) 16,700,000 shares of Common Stock and ii) 7,788,600 shares issuable upon exercise of options to purchase Common Stock.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares represented in Rows 6, 8 and 9 consist of i) 16,700,000 shares of Common Stock and ii) 7,788,600 shares issuable upon exercise of options to purchase Common Stock.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares represented in Rows 6, 8 and 9 consist of i) 16,700,000 shares of Common Stock and ii) 7,788,600 shares issuable upon exercise of options to purchase Common Stock.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares represented in Rows 6, 8 and 9 consist of i) 16,700,000 shares of Common Stock and ii) 7,788,600 shares issuable upon exercise of options to purchase Common Stock.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares represented in Rows 6, 8 and 9 consist of i) 16,700,000 shares of Common Stock and ii) 7,788,600 shares issuable upon exercise of options to purchase Common Stock.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares represented in Rows 6, 8 and 9 consist of i) 16,700,000 shares of Common Stock and ii) 7,788,600 shares issuable upon exercise of options to purchase Common Stock.


SCHEDULE 13G



MFN Partners, LP
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/28/2026
MFN Partners GP, LLC
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/28/2026
MFN Partners Management, LP
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/28/2026
MFN Partners Management, LLC
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/28/2026
Michael F. DeMichele
Signature:/s/ Michael F. DeMichele
Name/Title:Michael F. DeMichele, individually
Date:10/28/2026
Farhad Nanji
Signature:/s/ Farhad Nanji
Name/Title:Farhad Nanji, individually
Date:10/28/2026
Exhibit Information

Exhibit 1 - Joint Filing Agreement

Keep reading